We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Issues Emergency Stay of ITC’s 21-Month U.S. Ban on Botox Competitor
Court Issues Emergency Stay of ITC’s 21-Month U.S. Ban on Botox Competitor
A U.S. appeals court judge this week issued an emergency stay of a December ruling by the U.S. International Trade Commission that the import, sale and marketing of a competitor to AbbVie ’s Botox wrinkle treatment, Jeuveau, must be stopped for nearly two years.